Singapore markets closed

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
69.44-0.25 (-0.36%)
As of 02:46PM EDT. Market open.

ANI Pharmaceuticals, Inc.

210 Main Street West
Baudette, MN 56623
United States
218 634 3500
https://www.anipharmaceuticals.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees642

Key executives

NameTitlePayExercisedYear born
Mr. Nikhil LalwaniPresident, CEO & Director1.31MN/A1978
Mr. Stephen P. CareySenior VP of Finance & CFO751kN/A1971
Mr. James G. MarkenSenior Vice President of Operations & Product Development673.23kN/A1963
Mr. Christopher K. MutzHead of Rare Disease565.17kN/A1972
Mr. Ori GutwergSenior Vice President of Generics623.89kN/A1974
Mr. Muthusamy Shanmugam MS R.Ph.Head of R&D, COO of Novitium Operations & DirectorN/AN/A1968
Ms. Meredith W. CookSenior VP, General Counsel & Corporate SecretaryN/AN/A1974
Mr. Chad GassertSenior Vice President of Corporate Development & StrategyN/AN/A1976
Ms. Krista L. DavisChief Human Resources OfficerN/AN/A1973
Ms. Elizabeth Powell J.D.Chief Compliance Officer & Head of Legal of Rare DiseaseN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Corporate governance

ANI Pharmaceuticals, Inc.’s ISS governance QualityScore as of 1 March 2024 is 6. The pillar scores are Audit: 10; Board: 5; Shareholder rights: 6; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.